Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

NEW YORK - Lucid Diagnostics Inc. (NASDAQ:LUCD), a subsidiary of PAVmed Inc. (NASDAQ:PAVM), is set to be included in the Russell 2000 and Russell 3000 Indexes after U.S. markets close on June 27 ...

Their EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device are the only commercially available tools designed for early detection of esophageal precancer. The company has ...

Steve Dorsey has issued a stark warning for his fellow firefighters to check on one common undetected cancer symptom.